1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1198-A1198 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1155

Full text available